Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,118
Views
12
CrossRef citations to date
0
Altmetric
Brief Report

Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model

Renske J. E. van den Bijgaarta Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The NetherlandsView further author information
,
Michiel Kroesenb Holland Proton Therapy Center, Delft, The NetherlandsView further author information
,
Ingrid C. Broka Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The NetherlandsView further author information
,
Daphne Reijnenc Central Animal Laboratory, Radboud University Medical Center, Nijmegen, The NetherlandsView further author information
,
Melissa Wassinka Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The NetherlandsView further author information
,
Louis Boond Bioceros, Utrecht, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-0937-9171View further author information
ORCID Icon,
Peter M. Hoogerbruggee Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The NetherlandsORCID Iconhttps://orcid.org/0000-0003-3012-6109View further author information
ORCID Icon &
Gosse J Ademaa Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The NetherlandsCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6750-1665View further author information
ORCID Icon show all
Article: 1817653 | Received 17 Mar 2020, Accepted 27 Aug 2020, Published online: 20 Sep 2020

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Adeiye A. Pilgrim, Hunter C. Jonus, Andrew Ho, Anna C. Cole, Jenny Shim & Kelly C. Goldsmith. (2023) The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1. OncoImmunology 12:1.
Read now
Miguel F. Segura, Aroa Soriano, Josep Roma, Olga Piskareva, Carlos Jiménez, Ariadna Boloix, Jamie I. Fletcher, Michelle Haber, Juliet C. Gray, Leonor Cerdá-Alberich, Blanca Martínez de Las Heras, Adela Cañete, Soledad Gallego & Lucas Moreno. (2022) Methodological advances in the discovery of novel neuroblastoma therapeutics. Expert Opinion on Drug Discovery 17:2, pages 167-179.
Read now

Articles from other publishers (10)

Xuefeng Li, Kristin Huntoon, Yifan Wang, DaeYong Lee, Shiyan Dong, Abin Antony, Carl Walkey, Betty Y.S. Kim & Wen Jiang. (2024) Radiation Synergizes with IL2/IL15 Stimulation to Enhance Innate Immune Activation and Antitumor Immunity. Molecular Cancer Therapeutics 23:3, pages 330-342.
Crossref
Xuefeng Jin & Guang-Yu Yang. (2023) Pathophysiological roles and applications of glycosphingolipids in the diagnosis and treatment of cancer diseases. Progress in Lipid Research 91, pages 101241.
Crossref
Chiara Vitale, Cristina Bottino & Roberta Castriconi. (2023) Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells. Cells 12:6, pages 885.
Crossref
Bi Lian, Xiaosong Chen & Kunwei Shen. (2023) Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer. Frontiers in Immunology 14.
Crossref
Zsuzsanna Gaál. (2022) Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies. Biomolecules 13:1, pages 61.
Crossref
Annelisa M Cornel, Ester Dunnebach, Damon A Hofman, Sanjukta Das, Satyaki Sengupta, Femke van den Ham, Judith Wienke, Josephine G M Strijker, Denise A M H van den Beemt, Anke H W Essing, Bianca Koopmans, Sem A G Engels, Vania Lo Presti, Celina S Szanto, Rani E George, Jan J Molenaar, Sebastiaan van Heesch, Miranda P Dierselhuis & S Nierkens. (2022) Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch. Journal for ImmunoTherapy of Cancer 10:12, pages e005002.
Crossref
Godfrey Chi-Fung Chan & Carol Matias Chan. (2022) Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma. Biomolecules 12:3, pages 358.
Crossref
Roberto Ciaccio, Piergiuseppe De Rosa, Sara Aloisi, Marta Viggiano, Leonardo Cimadom, Suleman Khan Zadran, Giovanni Perini & Giorgio Milazzo. (2021) Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs. International Journal of Molecular Sciences 22:23, pages 12883.
Crossref
Pauline Thomas, Natacha Galopin, Emma Bonérandi, Béatrice Clémenceau, Sophie Fougeray & Stéphane Birklé. (2021) CAR T Cell Therapy’s Potential for Pediatric Brain Tumors. Cancers 13:21, pages 5445.
Crossref
Xiaofeng Dai, Danjun Wang & Jianying Zhang. (2021) Programmed cell death, redox imbalance, and cancer therapeutics. Apoptosis 26:7-8, pages 385-414.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.